VivoSim Labs (VIVS) Other Working Capital Changes (2017 - 2019)
VivoSim Labs (VIVS) posted quarterly Other Working Capital Changes of -$532000.0 for Q3 2019, down 1946.15% year-over-year from $28816.7 in Q3 2018, and down 7700.0% quarter-over-quarter from $7000.0 in Q2 2019.
VivoSim Labs (VIVS) Other Working Capital Changes (2017 - 2019) Analysis & Trends
VivoSim Labs' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$532000.0 for Q3 2019.
- In Q3 2019, Other Working Capital Changes fell 1946.15% year-over-year to -$532000.0; the TTM figure through Jun 2020 stood at -$532000.0 (down 370.8% YoY), while the FY2020 annual figure was -$525000.0, down 224.07% from the prior year.
- Other Working Capital Changes for Q3 2019 stood at -$532000.0, down from $7000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $425000.0 in Q4 2022, with the low at -$260000.0 in Q1 2024.
- The 5-year median for Other Working Capital Changes is -$149000.0 (2023), against an average of -$93411.8.
- Peak annual rise in Other Working Capital Changes reached 116.67% in 2019, while the deepest fall reached 1946.15% in 2019.
- VivoSim Labs' Other Working Capital Changes stood at $179000.0 in 2017, then plunged by 121.79% to -$39000.0 in 2018, then plunged by 1264.1% to -$532000.0 in 2019.
- Business Quant data shows VIVS's Other Working Capital Changes at -$532000.0 in Q3 2019, $7000.0 in Q2 2019, and -$55000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -532,000.00 |
| Sep 30, 2019 | -532,000.00 |
| Sep 30, 2019 | -532,000.00 |
| Jun 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 7,000.00 |
| Mar 31, 2019 | -55,000.00 |
| Mar 31, 2019 | -55,000.00 |
| Mar 31, 2019 | -55,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Sep 30, 2018 | -26,000.00 |
| Sep 30, 2018 | -26,000.00 |
| Sep 30, 2018 | -26,000.00 |
| Jun 30, 2018 | -42,000.00 |
| Jun 30, 2018 | -42,000.00 |
| Jun 30, 2018 | -42,000.00 |
| Mar 31, 2018 | -417,000.00 |
| Mar 31, 2018 | -417,000.00 |